Ameriprise’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Ameriprise’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,795	Closed	-$1.1M	–	3883
2020 Q3	$1.1M	Sell	20,795 -112	-0.5%	-$6.91K	﹤0.01%	2927
2020 Q2	$1.28M	Buy	20,907 +3,197	+18%	+$185K	﹤0.01%	2810
2020 Q1	$1M	Sell	17,710 -376	-2%	-$21.4K	﹤0.01%	2824
2019 Q4	$1.03M	Buy	18,086 +247	+1%	+$13.1K	﹤0.01%	3041
2019 Q3	$954K	Buy	+17,839	New	+$1.04M	﹤0.01%	3035
2016 Q1	–	Sell	-55,006	Closed	-$2.36M	–	3918
2015 Q4	$2.36M	Buy	55,006 +11,025	+25%	+$552K	﹤0.01%	2506
2015 Q3	$1.92M	Buy	43,981 +34,010	+341%	+$1.84M	﹤0.01%	2639
2015 Q2	$515K	Buy	9,971 +1,952	+24%	+$83.2K	﹤0.01%	3433
2015 Q1	$314K	Buy	+8,019	New	+$314K	﹤0.01%	3394

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ameriprise's BSTC Position: Q4 2020 in Review

Ameriprise sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 20,795 shares — an estimated $1.1M sold.

Ameriprise first reported a position in BSTC in Q1 2015 and held it in 9 quarters. The position peaked at $2.36M in Q4 2015. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Ameriprise reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Ameriprise sold 20,795 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.1M.
Ameriprise first reported a position in BioSpecifics Technologies Corp. in Q1 2015 and held it in 9 quarters.
Ameriprise's BioSpecifics Technologies Corp. position peaked at $2.36M in Q4 2015.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.